During the past decade, Hopital Des Enfants; Service d Hemato-Oncologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Des Enfants; Service d Hemato-Oncologie" are "High Grade Glioma" (1 trials) and "Sarcoma" (1 trials). Many other conditions were trialed in "Hopital Des Enfants; Service d Hemato-Oncologie" in a lesser frequency.

Most popular intervention types in "Hopital Des Enfants; Service d Hemato-Oncologie" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Radiotherapy" (1 trials), "Standard chemotherapy" (1 trials), "Temozolomide (TMZ)" (1 trials) and "bevacizumab [Avastin]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Des Enfants; Service d Hemato-Oncologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Des Enfants; Service d Hemato-Oncologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopital Des Enfants; Service d Hemato-Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Des Enfants; Service d Hemato-Oncologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".